Evidence map›Paper›PMID 28050710›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2017

The Copper bis(thiosemicarbazone) Complex Cu

Mikko T Huuskonen, Qing-Zhang Tuo, Sanna Loppi, Hiramani Dhungana, Paula Korhonen, Lachlan E McInnes, Paul S Donnelly, Alexandra Grubman, Sara Wojciechowski, Katarina Lejavova and 12 more

Open access · bronzeAbstract read
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 68 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Copper Homeostasis and Cuproptosis in Neurological Disorders.Drug design, development and therapy · 2026
    Review
  5. Observational
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Mechanism of Metal Complexes in Alzheimer's Disease.International journal of molecular sciences · 2024
    Review
  14. Integrated elemental analysis supports targeting copper perturbations as a therapeutic strategy in multiple sclerosis.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2024
    Article
  15. Article
  16. Article
  17. Impact of aging on copper isotopic composition in the murine brain.Metallomics : integrated biometal science · 2024
    Article
  18. Article
  19. Review
  20. The Role of Copper Homeostasis in Brain Disease.International journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 3 countries.

Mikko T HuuskonenDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Qing-Zhang TuoKey Laboratory of Ministry of Education of China for Neurological Disorders, Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Sanna LoppiDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Hiramani DhunganaDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Paula KorhonenDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Lachlan E McInnesSchool of Chemistry and Bio21 Institute for Molecular Science and Biotechnology, The University of Melbourne, Parkville, Victoria, Australia.
Paul S DonnellySchool of Chemistry and Bio21 Institute for Molecular Science and Biotechnology, The University of Melbourne, Parkville, Victoria, Australia.
Alexandra GrubmanDepartment of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
Sara WojciechowskiDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Katarina LejavovaDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Yuriy PomeshchikDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Laura PeriviitaDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Lotta KosonenDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Martina GiordanoDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Frederick R WalkerSchool of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.
Rong LiuKey Laboratory of Ministry of Education of China for Neurological Disorders, Department of Pathophysiology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Ashley I BushFlorey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia.
Jari KoistinahoDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Tarja MalmDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland.
Anthony R WhiteFlorey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. tony.white@qimrberghofer.edu.au.
Peng LeiFlorey Institute of Neuroscience and Mental Health, The University of Melbourne, Parkville, Victoria, Australia. peng.lei@scu.edu.cn.
Katja M KanninenDepartment of Neurobiology, A.I.Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland. katja.kanninen@uef.fi.
University of Eastern Finland · FIUniversity of Melbourne · AUFlorey Institute of Neuroscience and Mental Health · AUHuazhong University of Science and Technology · CNUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Developing new therapies for stroke is urgently needed, as this disease is the leading cause of death and disability worldwide, and the existing treatment is only available for a small subset of patients. The interruption of blood flow to the brain during ischemic stroke launches multiple immune responses, characterized by infiltration of peripheral immune cells, the activation of brain microglial cells, and the accumulation of immune mediators. Copper is an essential trace element that is required for many critical processes in the brain. Copper homeostasis is disturbed in chronic neurodegenerative diseases and altered in stroke patients, and targeted copper delivery has been shown to be protective against chronic neurodegeneration. This study was undertaken to assess whether the copper bis(thiosemicarbazone) complex, Cu

Indexed as

AnimalsBrainBrain IschemiaCalcium-Binding ProteinsCell Line, TumorCell SurvivalCoordination ComplexesDisease Models, AnimalEncephalitisLeukocyte Common AntigensMaleMiceMice, Inbred BALB CMice, Inbred C57BLMicrofilament ProteinsMicrogliaAif1 protein, mouseCalcium-Binding ProteinsCoordination Complexescopper (II) diacetyl-di(N(4)-methylthiosemicarbazone)Leukocyte Common AntigensMicrofilament ProteinsNeuroprotective AgentsOrganometallic CompoundsPtprc protein, mouseThiosemicarbazonesCuII(atsm)MicrogliaNeuroinflammationNeuronStroke

Identifiers

PMID28050710
PMCPMC5398983
OpenAlexW2566372983

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.